Company Search:
Advanced Search
Sponsored Links
AstraZeneca PLC- ADR Company Snapshot
AstraZeneca PLC- ADR operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC- ADR with three other companies in this sector in the United States: Abbott Laboratories (2015 sales of $20.41 billion of which 34% was Nutritionals), Abbvie Inc ($22.86 billion of which 100% was Pharmaceutical Products), and Eli Lilly and Company ($19.96 billion of which 35% was Endocrinology).

Sales Analysis. During the year ended December of 2015, sales at AstraZeneca PLC- ADR were $24.71 billion. This is a decrease of 5.3% versus 2014, when the company's sales were $26.10 billion.
  Stock Performance Chart for AstraZeneca PLC- ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 28.58
(Figures in U.S. Dollars)
1 Week 0.5%   13 Weeks 2.6%  
4 Weeks -6.6%   52 Weeks -6.6%  
AstraZeneca PLC- ADR Key Data:
  Ticker: AZN Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 24,707,920,648
(Year Ending Jan 2016).
Employees: 61,500
  Currency: U.S. Dollars Market Cap: 72,307,400,000
  Fiscal Yr Ends: December Shares Outstanding: 2,530,000,000
  Share Type: Ordinary Closely Held Shares: 10,519,914
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.